1. Stocks
  2. Astec Lifesciences Ltd.
  3. Swot
Astec Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Stocks where Mutual Funds Increased Holdings in Past Month
Consistent Highest Return Stocks over Five Years - Nifty500
Rising Net Cash Flow and Cash from Operating activity 375.3% returns for Nifty 500 over 5.9 years
Company with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Promoter holding decreased by more than -2% QoQ -5.3% returns for over 0.2 years
Inefficient use of capital to generate profits - RoCE declining in the last 2 years -9.0% returns for Nifty 500 over 1.9 years
Decline in Net Profit with falling Profit Margin (QoQ)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
Promoter decreasing their shareholding
Fall in Quarterly Revenue and Net Profit (YoY)
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
30 Day SMA crossing over 200 Day SMA, and current price greater than open 34.5% returns for Nifty 500 over 1.2 years
High Momentum Scores (Technical Scores greater than 50) 319.5% returns for Nifty 500 over 5.1 years
Highest Recovery from 52 Week Low
Stocks with Expensive Valuations according to the Trendlyne Valuation Score 177.2% returns for Nifty 500 over 4.5 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income
Significant Change in Promoter Shareholding - Latest Quarter
Expensive Performers (DVM) 102.3% returns for over 5.4 years
Expensive Performers (DVM) 79.4% returns for over 5.4 years
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks 181.7% returns for Nifty 500 over 4.5 years
RSI indicating price weakness
Top Losers